5 Healthcare Stocks to Buy According to Billionaire Noam Gottesman’s GLG Partners

Page 5 of 5

1. Johnson & Johnson (NYSE:JNJ)

Noam Gottesman’s Stake Value: $293 million

Percentage of Noam Gottesman’s 13F Portfolio: 1.03%

Number of Hedge Fund Holders: 56

Johnson & Johnson (NYSE:JNJ) is one of the oldest companies in the United States since it was founded in 1886, roughly two decades after the civil war ended. It is also one of the most well-known companies in the world and sells its products in several sectors such as baby care, consumer health, medical devices, and pharmaceuticals.

Johnson & Johnson (NYSE:JNJ)’s biggest stakeholder is Terry Smith’s Fundsmith LLP, who owns 7.1 million shares of the company equaling $1.1 billion.

In its second quarter investor letter, Distillate Capital said the following about the company:

“The largest additions in the rebalance, Johnson & Johnson was around 50 and 40 basis points incrementally. J&J underperformed in the quarter while its normalized free cash flows held steady and so its position size was topped off to match the stable cash flows.”

Disclosure: None. You can also take a peek at the 15 Best Blue Chip Stocks to Buy Now and 10 Best Growth Stocks To Buy According to Ray Dalio.

Page 5 of 5